News
Featured projects
Discover the Foundation for Innovation in Cardiometabolism and Nutrition
Located in the heart of the Pitié-Salpêtrière hospital in Paris, the ICAN is a center of excellence in the field of cardiometabolic diseases: diabetes, obesity, hepatic diseases (steatosis), diseases of the heart and blood vessels.
168Médecins
221Chercheurs
186Articles de consensus et recommandations internationales
4Parcours de soins innovants
6Centres de référence Maladies rares
5167Publications scientifiques
Curing cardiometabolic diseases through translational research
We bring together all the scientific and medical expertise to support patients throughout their life course: prevention, early diagnosis, comprehensive and personalized care, acute episodes, monitoring of chronic diseases
Diabetes
Obesity
Heart and vessels
fatty liver
Collaborate with ICAN teams
We offer 360° expertise in cardiometabolism to support academic or industrial projects: assistance in setting up projects, clinical investigation platform, scientific platforms, legal support and research promotion
Clinical investigation platform
ICAN Clinical Investigation est un plateau d’investigation clinique dédié à la recherche biomédicale sur les maladies du cardiométabolisme. Les équipes d’ICAN Clinical Investigation accompagnent les promoteurs académiques ou industriels dans le montage de leurs essais cliniques.
Scientific platforms
The IHU-ICAN has structured, in the form of scientific platforms, a unique service offer to accelerate research on cardiometabolic diseases. These scientific platforms support the research mission of the scientific and medical community of the IHU and they are open to academic and industrial collaborations. Innovation is at the heart of their operation and their complementarity is a factor in accelerating scientific projects.
Located in the heart of the Pitié Salpêtrière hospital and relying on a scientific and clinical community of international stature, the IHU ICAN has forged numerous partnerships with pharmaceutical companies, from large groups to young biotechnology companies, in through research and development activities.
Support the ICAN Foundation
With the support of donors and patrons, the IHU ICAN is accelerating discoveries for the benefit of patients in metabolic diseases.
By supporting the ICAN Foundation, you participate in the development of comprehensive and tailor-made care for cardiometabolic diseases. With the support of donors and patrons, the ICAN Foundation is accelerating discoveries for the benefit of patients on metabolic diseases: diabetes, obesity, liver disease (NASH), cardiovascular diseases and inventing the medicine of tomorrow in cardiometamolism. This so-called 5P medicine: Personalized, Participatory, Predictive, Preventive and Proof is at the heart of the mobilization of ICAN experts. With your support, they will gain valuable time to advance research.
Every donation counts. Thank you for your support.
